{"title":"Effect of cranial electro-stimulation on cognition in perimenopausal women: randomized control study.","authors":"Naveeta Thakur, Nidhi Sharma, Simranjeet Kaur, Parveen Kumar, Preeti Kapri, Priyanka Negi","doi":"10.1080/13697137.2025.2530444","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate the efficacy of cranial electrotherapy stimulation (CES) on cognition among perimenopausal women.</p><p><strong>Methods: </strong>The pretest-post-test randomized controlled trial was conducted between April 2024 and January 2025. Forty-six perimenopausal women, aged 40-55 years, were randomized into two groups: active CES (<i>n</i> = 23) or sham CES (<i>n</i> = 23). Participants were blinded to the study. Both groups received 30-min sessions, 4 days a week for 4 weeks. The participants were assessed at baseline and at the end of 4 weeks of intervention using the Montreal Cognitive Assessment (MoCA) scale.</p><p><strong>Results: </strong>Demographic and baseline characteristics depicted a normal distribution for both groups, except for MoCA (<i>p</i> < 0.05). Within-group analyses of both groups demonstrated significant differences for MoCA (active CES, <i>p</i> = 0.001; sham CES, <i>p</i> = 0.002) with large effect size ≥ 0.5. Between-group analyses of MoCA showed no significant difference with <i>p</i> = 0.212 and small effect size ≤ 0.3. The time and group interaction effect showed significant improvement with <i>p</i> = 0.001.</p><p><strong>Conclusions: </strong>CES has the potential to enhance cognitive function in perimenopausal women. Additionally, no adverse events related to the study were reported.</p>","PeriodicalId":10213,"journal":{"name":"Climacteric","volume":" ","pages":"1-6"},"PeriodicalIF":3.2000,"publicationDate":"2025-08-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Climacteric","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13697137.2025.2530444","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: The aim of this study was to investigate the efficacy of cranial electrotherapy stimulation (CES) on cognition among perimenopausal women.
Methods: The pretest-post-test randomized controlled trial was conducted between April 2024 and January 2025. Forty-six perimenopausal women, aged 40-55 years, were randomized into two groups: active CES (n = 23) or sham CES (n = 23). Participants were blinded to the study. Both groups received 30-min sessions, 4 days a week for 4 weeks. The participants were assessed at baseline and at the end of 4 weeks of intervention using the Montreal Cognitive Assessment (MoCA) scale.
Results: Demographic and baseline characteristics depicted a normal distribution for both groups, except for MoCA (p < 0.05). Within-group analyses of both groups demonstrated significant differences for MoCA (active CES, p = 0.001; sham CES, p = 0.002) with large effect size ≥ 0.5. Between-group analyses of MoCA showed no significant difference with p = 0.212 and small effect size ≤ 0.3. The time and group interaction effect showed significant improvement with p = 0.001.
Conclusions: CES has the potential to enhance cognitive function in perimenopausal women. Additionally, no adverse events related to the study were reported.
期刊介绍:
Climacteric is the official journal of the International Menopause Society (IMS). As an international peer-reviewed journal it publishes original research and reviews of all aspects of aging in women.
Climacteric was founded by the IMS in 1998 and today has become a leading journal in the publication of peer-reviewed papers on the menopause, climacteric and mid-life health. Topics covered include endocrine changes, symptoms attributed to the menopause and their treatment, hormone replacement and alternative therapies, lifestyles, and the counselling and education of peri- and postmenopausal women. Climacteric, published bimonthly, also features regular invited reviews, editorials and commentaries on recent developments.
The editorial review board of Climacteric includes leading scientific and clinical experts in the field of midlife medicine and research and is headed by its Editor-in-Chief, Professor Rod Baber of Australia. He and his team of Associate Editors act independently to set a clear editorial policy, co-ordinate peer review, and ensure a rapid response to submitted papers.